l9n/ Oregon

2025 Regular Session

House Bill 2057

Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers from requiring that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug.

Did not become law. It stopped in the House of Representatives's Behavioral Health and Health Care Committee on June 27, 2025. The 2025 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Digest: Tells insurers and PBMs not to require that drugs be labeled as 340B drugs in a claim for repayment. (Flesch Readability Score: 62.8). Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers from requiring that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug. Takes effect on the 91st day following adjournment sine die.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

2 co-sponsors

Cyrus Javadi, Ed Diehl

Its course

January 13 to June 27, 2025, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action5 actions on 5 days

In the House of RepresentativesJan 13 to Jun 27 · stopped165 days

Waiting for a committeeJan 13 to Jan 174 days

Behavioral Health and Health CareJan 17 to Jun 27 · stopped161 days

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the House of Representatives Jan 13 – Jun 27

  1. Introduced
  2. Sent to Behavioral Health and Health Care
  3. Heard in Behavioral Health and Health Care
  4. Heard in Behavioral Health and Health Care
  5. Died when the session ended
All 5 actions, as published